Skip to main content
. 2016 Apr 14;11(4):e0153187. doi: 10.1371/journal.pone.0153187

Fig 8. The melanocortin receptor antagonist SHU9119 had no effect on the cardiorespiratory responses to opto-stimulation.

Fig 8

Systemic administration of SHU9119 (2μM) had no effect on the (A) bradycardia, (B) RSA responses, and (C) bradypnoeic responses to opto-stimulation of NTSPOMC neurons in the WHBP. Data are represented as mean±SEM. Wilcoxon matched-pairs signed rank tests (n = 7).